Filing Details

Accession Number:
0001714899-24-000177
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-15 16:10:01
Reporting Period:
2024-08-13
Accepted Time:
2024-08-15 16:10:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1714899 Denali Therapeutics Inc. DNLI Biological Products, (No Disgnostic Substances) (2836) 463872213
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1724311 O. Alexander Schuth C/O Denali Therapeutics Inc.
161 Oyster Point Blvd.
South San Francisco CA 94080
Cofo And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-13 2,272 $22.89 186,419 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 523,749 Indirect See footnote
Footnotes
  1. Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
  2. Includes 123,810 RSUs.
  3. Includes 1,350 shares acquired under the ESPP Purchase on May 31, 2024.
  4. The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.